Back

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

5 December 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Echocardiography: Systolic and Diastolic Function Systolic and Diastolic Function EACVI Premium Access EuroEcho-Imaging 2018

About the speaker

Photo
Doctor Iacopo Fabiani

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)

10 More presentations in this session

Presentation thumbnail
Early a small decline in left ventricular ejection fraction can predict trastuzumab-related cardiotoxicity in patients with breast cancer: A study using 13 years of registry data
Doctor E. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Hemodynamic insights of the anrep effect in men using echo-derived pressure-volume analysis
Doctor J. Reil (Luebeck, DE)
Presentation thumbnail
New multiparametric evaluation of dyssynchrony, machine learning and prediction of response to cardiac resynchronization therapy
Mr A. Hubert (Rennes, FR)
Abstract
Presentation thumbnail
Predictive value of echocardiographic measurement for evaluating diastolic dysfunction in chronic atrial fibrillation patients with preserved left ventricular ejection fraction
Doctor J. Ahn (Gumi, KR)
Abstract Slides
Presentation thumbnail
Initial diastolic vortex formation in the left ventricle relates to the atrioventricular plane motion of the outflow tract
Mrs A. Daae (Trondheim, NO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Echocardiography: Systolic and Diastolic Function

The Event

Event poster

EuroEcho-Imaging 2018

5 December - 8 December 2018
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources